| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 9.9e-05 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 9.8e-05 | 1 |